|1.||Dumontet, Charles: 3 articles (01/2009 - 02/2007)|
|2.||Guerrini, Renzo: 2 articles (11/2013 - 01/2004)|
|3.||Ma, Jinyou: 2 articles (12/2010 - 01/2010)|
|4.||Zhang, Mingchang: 2 articles (12/2010 - 01/2010)|
|5.||Xu, Xun: 2 articles (12/2010 - 01/2010)|
|6.||Beghin, Anne: 2 articles (01/2009 - 02/2007)|
|7.||Matera, Eva-Laure: 2 articles (10/2008 - 02/2007)|
|8.||Eraslan, Cenk: 1 article (01/2016)|
|9.||Serdaroglu, Gul: 1 article (01/2016)|
|10.||Tekin, Hande: 1 article (01/2016)|
04/01/2006 - "To characterize the time course of apoptosis and degeneration in a transgenic mouse model of retinal degeneration based on truncated mutant HRG4; to investigate the nature of binding of the mutant HRG4 to its target, ADP-ribosylation factor-like (ARL)2; to study its effects on the downstream molecules Binder-of-ARL2 (BART) and adenine nucleotide transporter (ANT)-1 and on the induction of apoptosis. "
12/01/2010 - "Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells."
04/22/2010 - "Secondary screening of these genes using custom microarray chips identified ASAP1, a multi-domain adaptor protein with ADP-ribosylation factor-GAP activity, as being potentially involved in tumor progression. "
10/01/2006 - "Variants in the tumor suppressor gene ARLTS1 (ADP-ribosylation factor-like tumor-suppressor gene 1) have been shown to influence familial cancer risk. "
10/01/2002 - "Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors."
09/01/2006 - "Involvement of a novel ADP-ribosylation factor GTPase-activating protein, SMAP, in membrane trafficking: implications in cancer cell biology."
|3.||Breast Neoplasms (Breast Cancer)
01/28/2012 - "Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration."
01/01/2009 - "ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice."
02/01/2007 - "ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells."
09/08/2011 - "The ADP-ribosylation factors (ARFs) 1 and 6 are small GTP-binding proteins, highly expressed and activated in several breast cancer cell lines and are associated with enhanced migration and invasiveness. "
01/01/2009 - "We have previously reported that ADP ribosylation factor like 2 (Arl2), a small GTPase, content influences microtubule dynamics and cell cycle distribution in breast tumor cells, as well as the degree and distribution of phosphorylated P53. "
12/01/2010 - "ADP-ribosylation factors (Arfs) that play an essential role in intracellular trafficking and organelle structure are small GTP-binding proteins, which have been identified recently to be involved in virus infection. "
01/01/2010 - "However, the ADP ribosylation factors (Arfs), also belonging to the regulatory GTP-binding proteins and playing a central role in membrane trafficking, have not been reported yet in shrimp and their relationship with WSSV infection is completely unknown to date. "
06/28/2011 - "During Pseudomonas syringae pathovar tomato (Pst) DC3000 infection of Arabidopsis, a host ADP ribosylation factor guanine nucleotide exchange factor, AtMIN7, is destabilized by the pathogen effector HopM1 through the host 26S proteasome. "
08/01/2010 - "Several genes from the resistant sample (14-3-3 protein, wali5 protein, actin-depolymerization factor and ADP-ribosylation factor) and the susceptible sample (brown plant hopper resistance protein, caffeic acid O-methyltransferase, pathogenesis-related protein and senescence-associated protein) were selected and their differential expression in the resistant and susceptible samples collected at different time points after leaf rust infection was confirmed by RT-PCR analysis. "
|5.||Periventricular Nodular Heterotopia
01/01/2016 - "Mutations in ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) gene was recently recognized to cause bilateral periventricular nodular heterotopia, putaminal hyperintensity and movement disorder. "
11/01/2013 - "Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology. "
|2.||Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)
|3.||GTP-Binding Proteins (G-Protein)
|5.||GTPase-Activating Proteins (GTPase-Activating Protein)
|6.||Proteins (Proteins, Gene)
|7.||GTP Phosphohydrolases (GTPases)
|8.||14-3-3 Proteins (14-3-3 Protein)